Your session is about to expire
← Back to Search
Ventilator Protocol for Pediatric Acute Respiratory Distress Syndrome
N/A
Recruiting
Led By Christopher J Newth, MD
Research Sponsored by Children's Hospital Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Children > 1 month of age and >44 weeks gestation and ≤ 18 years of age supported on mechanical ventilation with pulmonary parenchymal disease (i.e. Pediatric Acute Respiratory Distress Syndrome (PARDS)) with Oxygen Saturation Index (OSI) ≥ 5) or Oxygenation Index (OI) ≥ 4
Be younger than 65 years old
Must not have
Conditions precluding the use of permissive hypercapnia or hypoxemia (i.e. intracranial hypertension, severe pulmonary hypertension)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion - each patient will be capped at 28 days, limitation of care, or death, whichever comes first.
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a computer program that gives doctors recommendations on how to ventilate children with a certain lung disease. They want to see if the program is usable in different hospitals and if it leads to shorter ventilator use.
Who is the study for?
This trial is for children over 1 month old and under 18 years who need mechanical ventilation due to severe lung problems (PARDS) and are expected to be on a ventilator for more than 72 hours. It's not for patients whose doctors refuse participation or those with conditions that make certain breathing strategies unsafe.
What is being tested?
The study tests a Clinical Decision Support tool designed to help doctors manage ventilators in pediatric ICUs based on the best evidence available. The goal is to see if this tool can standardize care, ensure adherence to recommendations, and potentially shorten time on ventilation.
What are the potential side effects?
Since this trial involves implementing a decision support protocol rather than a drug, there aren't direct side effects like medications have. However, changes in ventilator management could impact patient comfort or respiratory function.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My child is on a ventilator due to severe lung disease and meets the age and oxygenation criteria.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have conditions like severe brain or lung pressure that prevent certain treatments.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion - each patient will be capped at 28 days, limitation of care, or death, whichever comes first.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion - each patient will be capped at 28 days, limitation of care, or death, whichever comes first.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Aim 1: Implementation Feasibility
Aim 2: Protocol Adherence
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Ventilator management using the proposed protocol in both acute and weaning phases
Find a Location
Who is running the clinical trial?
Children's Hospital Los AngelesLead Sponsor
248 Previous Clinical Trials
5,074,444 Total Patients Enrolled
1 Trials studying Ventilator-Induced Lung Injury
240 Patients Enrolled for Ventilator-Induced Lung Injury
Christopher J Newth, MDPrincipal InvestigatorChildren's Hospital Los Angeles
1 Previous Clinical Trials
55 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger